|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,650.36 |
3.42% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$64,098.60 |
3.10% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$60,039.80 |
2.91% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$52,321.65 |
2.53% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$52,124.04 |
2.52% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,785.44 |
2.36% |
| Waters Corporation |
WAT |
941848103 |
148 |
$48,641.68 |
2.36% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$48,391.08 |
2.34% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$46,651.62 |
2.26% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$46,456.29 |
2.25% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$45,501.13 |
2.20% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$45,159.32 |
2.19% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$45,148.91 |
2.19% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$44,855.41 |
2.17% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$44,906.30 |
2.17% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$44,229.24 |
2.14% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,257.46 |
2.14% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$43,042.10 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$42,672.43 |
2.07% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$42,537.88 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
169 |
$42,449.42 |
2.06% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$41,784.25 |
2.02% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$41,616.25 |
2.01% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,329.20 |
2.00% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$40,788.44 |
1.97% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$40,619.94 |
1.97% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$40,123.57 |
1.94% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$39,149.12 |
1.90% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$39,048.58 |
1.89% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$38,774.78 |
1.88% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$38,100.10 |
1.84% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,674.63 |
1.82% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$37,341.20 |
1.81% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$37,193.12 |
1.80% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$36,891.28 |
1.79% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$37,062.16 |
1.79% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$36,434.60 |
1.76% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$36,032.26 |
1.74% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$35,560.74 |
1.72% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$34,378.25 |
1.66% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$33,769.19 |
1.64% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$33,292.92 |
1.61% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$32,340.06 |
1.57% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$32,186.61 |
1.56% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$31,650.96 |
1.53% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$31,635.70 |
1.53% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$31,676.57 |
1.53% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$30,329.63 |
1.47% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$27,765.55 |
1.34% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$25,578.69 |
1.24% |
| US Dollar |
$USD |
|
2,302 |
$2,302.00 |
0.11% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|